1.
Dig Liver Dis
; 46(7): 659-60, 2014 Jul.
Article
in English
| MEDLINE
| ID: mdl-24631030
Subject(s)
Carcinoma, Hepatocellular/diagnostic imaging , Liver Neoplasms/diagnostic imaging , Neoplasm Regression, Spontaneous , Neoplasms, Multiple Primary/diagnostic imaging , Aged , Aloe , Carcinoma, Hepatocellular/pathology , Humans , Liver Neoplasms/pathology , Male , Neoplasms, Multiple Primary/pathology , Plant Preparations/therapeutic use , Radiography , Self Medication
2.
Recenti Prog Med
; 104(4): 168-76, 2013 Apr.
Article
in Italian
| MEDLINE
| ID: mdl-23748641
ABSTRACT
Surgery is an almost inevitable event in Crohn's disease but is not curative; post-operative recurrence follows a sequential and predictable course. Prevention of post-operative recurrence in Crohn's disease is therefore a relevant problem in the management of the disease. Several drugs have been evaluated to decrease the risk of recurrence: these include mesalazine, antibiotics, probiotics, budesonide, thiopurines and biologic agents. This review focuses on the randomised controlled trials and meta-analyses addressing different drugs and strategies for preventing post-operative recurrence in Crohn's disease.